A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix.
about
The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysisPregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case reportOvulation induction disrupts luteal phase function.Patient scheduling for gonadotrophin-releasing hormone antagonist protocols.Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study.New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists.The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols.Should mild stimulation be the order of the day?The value of delaying hCG administration to enable maturation of medium-sized follicles in patients undergoing superovulation for IVF/ICSI.Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.Comparison of outcomes and direct cost between minimal stimulation and conventional protocols on ovarian stimulation in in vitro fertilization.Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation.
P2860
Q24816913-5E7DEC31-E376-4147-B747-006F2C047344Q28293370-F3727E2F-3343-48D7-A15A-8DECBE68020FQ28362146-73744090-E06F-4ED4-96C9-983236E39907Q34397303-FFCE1477-EFAE-49A4-82A6-B094557F3F51Q34591678-35201D14-C39F-461E-9D71-E431F668EE1CQ35186866-3DDE08DC-038B-4784-9C5B-C30F3C04CC04Q36249876-8A5FF6E1-3ACB-47B3-958F-0A4075A6A41AQ36271941-29AC41B8-B357-4EF8-AC19-EA36A0B9E19DQ37370067-DBCBB58D-5583-4E48-8A63-3CB2FE0D5871Q37658023-31AEDB84-5390-4049-A361-FC167B8F4228Q47891338-866B344C-0886-40F0-9544-8AF42053CDCCQ48787898-64B4CF3E-92B2-4643-BF49-1113F025FFECQ50657308-8798E43D-4063-440B-9EDC-A9E490D2A88FQ52003232-BFA48C9E-AF43-40CE-AFB1-EF02D53C8D86
P2860
A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A pilot study involving minima ...... hormone antagonist cetrorelix.
@en
A pilot study involving minima ...... hormone antagonist cetrorelix.
@nl
type
label
A pilot study involving minima ...... hormone antagonist cetrorelix.
@en
A pilot study involving minima ...... hormone antagonist cetrorelix.
@nl
prefLabel
A pilot study involving minima ...... hormone antagonist cetrorelix.
@en
A pilot study involving minima ...... hormone antagonist cetrorelix.
@nl
P2093
P1476
A pilot study involving minima ...... hormone antagonist cetrorelix.
@en
P2093
B C Fauser
N S Macklon
P304
P356
10.1016/S0015-0282(00)00414-3
P407
P577
2000-05-01T00:00:00Z